Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...
In the aftermath of the Department of Health and Human Services’ (HHS) response to a pending lawsuit against the federal ...
RFK also opposes fluoridation of water. Another patient, Judith, age 80, scoffs at such skepticism. She grew up in Niagara ...
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...
The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...
Investing.com -- Shares of Novo Nordisk (NYSE: NVO) fell 3.6% on Friday after the U.S. Department of Health and Human ...
The Biden Administration announced the next batch of 15 prescription drugs that will be included in price negotiations with companies — with the aim of lowering costs for people covered by Medicare.
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...